TP53 and prostate carcinoma: sSypELDTA was transfected into the mouse p53 and Rb deficient prostate adenocarcinoma cell lines PCN1 and PCN3, which were established from prostate carcinomas of PB-Cre4; p53loxP/loxPRbloxP/loxP mice [36].